ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Ferrata Storti Foundation
2019-02-01
|
| 叢編: | Haematologica |
| 在線閱讀: | https://haematologica.org/article/view/8789 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|